Observations are presented on the behavior of populations of tubercle bacilli in the tissues of mice during the administration of antimicrobial drugs. The behavior of the populations during therapy with any particular drug was different depending upon whether the tubercle bacilli were subsisting in the lung or in the spleen. Moreover, the pattern of microbial behavior was distinctive and predictable for each drug studied. Changes in the size of the populations of tubercle bacilli in the tissues appeared to be a more sensitive reflection of drug influence than microscopic study of the number and character of the tuberculous lesions. Nevertheless, in untreated animals, pulmonary lesions evolved and progressed steadily to a fatal outcome despite the fact that the populations of tubercle bacilli had stabilized at a relatively high census early in the course of therapy. The uniform persistence of tubercle bacilli in the spleen throughout prolonged drug administration was demonstrated with every drug or multiple drug regimens except for pyrazinamide when accompanied by isoniazid. Cultures of the bacilli which survived in the tissues despite antimicrobial therapy were highly susceptible to the drugs employed when tested in vitro. Thus the survival of the tubercle bacilli in the tissues represented microbial persistence rather than drug resistance. When pyrazinamide and isoniazid were administered together, it was not possible to detect the microorganisms in the spleen or lungs of treated animals. A detailed investigation of this apparent abolition of microbial persistence forms the subject of an accompanying report.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2136613PMC
http://dx.doi.org/10.1084/jem.104.5.737DOI Listing

Publication Analysis

Top Keywords

tubercle bacilli
28
bacilli tissues
16
populations tubercle
12
bacilli
8
tissues despite
8
antimicrobial therapy
8
behavior populations
8
microbial persistence
8
tubercle
7
drug
7

Similar Publications

Drug-Drug Interaction Between Rifampicin and Albuvirtide: A Phase 1, Randomized, Open-Label Study.

J Clin Pharmacol

January 2025

Department of Pharmacy, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Albuvirtide (ABT) is a novel long-acting fusion inhibitor for human immunodeficiency virus type 1 (HIV-1), and may be co-administered with rifampicin (RIF) in patients concurrent with tubercle bacillus and HIV-1. This study was conducted to investigate the pharmacokinetic effect of co-administration of the two drugs. In the study, 24 healthy volunteers were randomized to receive ABT alone or with RIF.

View Article and Find Full Text PDF
Article Synopsis
  • Cervical tuberculosis is rare, constituting only 0.1-0.65% of all tuberculosis cases, and presents primarily with symptoms like infertility, abnormal bleeding, pelvic pain, and amenorrhea, without any specific visible changes to the cervix.
  • A 45-year-old woman was misdiagnosed with cervical cancer, but further examination revealed she actually had tuberculosis of the cervix, highlighting the importance of proper diagnosis.
  • Tuberculosis can cause chronic pelvic inflammation and infertility, and clinicians should consider it as a potential diagnosis in cases of unexplained lower genital tract symptoms, since it can mimic more common conditions like cervical cancer.
View Article and Find Full Text PDF

Disseminated tuberculosis (TB) is a TB infection involving two or more noncontiguous sites. It is a challenging medical care due to its misleading presentation. Although it is associated with immunodepression, rare cases have been described in immunocompetent patients.

View Article and Find Full Text PDF

Although tuberculosis is an ancient disease, recognition of its airborne route of transmission, with implications for respiratory isolation, is only relatively recent. Since the time of Hippocrates, the dogma among health practitioners was that the disease was hereditary or that it could be contracted by inhaling "miasma", or corrupted air. Consequently, isolation of patients was not routine practice, and, in fact, patients with scrofula (morbus regius, or "king's evil) sought to be cured by the "royal touch" throughout the middle ages.

View Article and Find Full Text PDF

Because resistant variants of the disease are always emerging, tuberculosis is a global issue that affects economies. New antitubercular medications should be developed, and this can be done by inhibiting druggable targets. Enoyl acyl carrier protein (ACP) reductase (InhA) is a crucial enzyme for the survival of (MTB).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!